Proffitt & Goodson’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
700
+667
| +2,021% | +$520K | 0.08% | 84 |
|
|
2025
Q1 | $27.3K | Hold |
33
| – | – | ﹤0.01% | 183 |
|
|
2024
Q4 | $25.5K | Sell |
33
-6
| -15% | -$4.63K | ﹤0.01% | 178 |
|
|
2024
Q3 | $34.6K | Sell |
39
-20
| -34% | -$17.7K | 0.01% | 183 |
|
|
2024
Q2 | $53.4K | Buy |
+59
| New | +$53.4K | 0.01% | 161 |
|
|
2021
Q1 | – | Sell |
-20
| Closed | -$3K | – | 263 |
|
|
2020
Q4 | $3K | Sell |
20
-140
| -88% | -$21K | ﹤0.01% | 234 |
|
|
2020
Q3 | $24K | Hold |
160
| – | – | 0.01% | 164 |
|
|
2020
Q2 | $26K | Hold |
160
| – | – | 0.01% | 166 |
|
|
2020
Q1 | $22K | Hold |
160
| – | – | 0.01% | 142 |
|
|
2019
Q4 | $21K | Hold |
160
| – | – | ﹤0.01% | 144 |
|
|
2019
Q3 | $18K | Hold |
160
| – | – | ﹤0.01% | 151 |
|
|
2019
Q2 | $18K | Hold |
160
| – | – | ﹤0.01% | 142 |
|
|
2019
Q1 | $21K | Buy |
160
+20
| +14% | +$2.63K | 0.01% | 136 |
|
|
2018
Q4 | $16K | Hold |
140
| – | – | ﹤0.01% | 112 |
|
|
2018
Q3 | $15K | Buy |
+140
| New | +$15K | ﹤0.01% | 106 |
|